Literature DB >> 6349125

Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation.

P I Warkentin, R Yomtovian, D Hurd, R Brunning, J Swanson, J H Kersey, J McCullough.   

Abstract

A 26-year-old, blood group O bone marrow transplant recipient experienced a severe, delayed hemolytic transfusion reaction 6 days following transplantation of marrow from his HLA-mixed lymphocyte culture - identical, blood group AB sister. The patient's pretransplant serum contained both anti-A (IgG titer = 1:128; IgM = 1:32) and anti-B (IgG = 1:16; IgM = 1:64) which was reduced by a two-plasma volume plasma exchange followed by transfusion of four units of incompatible, donor type red cells. The patient experienced no immediate adverse reaction. On the 6th posttransplant day, he became acutely dyspneic. His hematocrit dropped to 18%; the direct antiglobulin test was positive for IgG and complement; anti-A and anti-B were eluted from his red cells. His peripheral blood smear demonstrated extensive agglutination resembling a mixed field reaction. This case demonstrates that significant morbidity may be associated with major ABO-incompatible bone marrow transplantation, that the transfusion of incompatible red cells should be undertaken with extreme caution, and that efforts should be continued to develop methods of pretransplant in vitro red cell removal from the infused bone marrow.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349125     DOI: 10.1111/j.1423-0410.1983.tb04120.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

Review 1.  The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Cecilia Rossi; Alessandro Lanti; Gaspare Adorno; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

2.  Immunoadsorption for removal of anti-A and anti-B blood group antibodies in ABO-incompatible bone marrow transplantation.

Authors:  B Osterwalder; A Gratwohl; C Nissen; B Speck
Journal:  Blut       Date:  1986-11

3.  Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study.

Authors:  José Alfreu Soares Júnior; Glaucia Helena Martinho; Antonio Vaz de Macedo; Marisa Ribeiro Verçosa; Vandack Nobre; Gustavo Machado Teixeira
Journal:  Hematol Transfus Cell Ther       Date:  2018-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.